A cost-effectiveness analysis of pneumococcal conjugate vaccines in infants and herd protection in older adults in Colombia

References

• Centers for Disease Control and Prevention. Pneumococcal Disease [Internet]. 2014; cited May 4, 2020. Available from: https://wwwnc.cdc.gov/travel/diseases/pneumococcal-disease-streptococcus-pneumoniae
   Google Scholar
• Tan TQ. Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines. Clin Microbiol Rev. 2012 Jul;25(3):409–419.
   PubMed Web of Science ®Google Scholar
• Lepoutre A, Varon E, Georges S, et al. impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001-2006. Euro Surveill. 2008 Aug 28;13(35):18962.
   PubMedGoogle Scholar
• Teixeira DC, Diniz LMO, Guimarães NS, et al. Risk factors associated with the outcomes of pediatric bacterial meningitis: a systematic review. J Pediatr (Rio J). 2020 March-April;96(2):159–167.
   PubMed Web of Science ®Google Scholar
• Choi C. Bacterial meningitis in aging adults. Clin Infect Dis. 2001 Oct 15;33(8):1380–1385.
   PubMed Web of Science ®Google Scholar
• Atkinson W, Hamborsky J, McIntyre L, et al., eds. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. 9h ed. Washington DC: Public Health Foundation; 2006.
   Google Scholar
• Karppinen S, Teräsjärvi J, Auranen K, et al. Acquisition and transmission of streptococcus pneumoniae are facilitated during rhinovirus infection in families with children. Am J Respir Crit Care Med. 2017 Nov 1;196(9):1172–1180.
   PubMed Web of Science ®Google Scholar
• Henriques-Normark B, Tuomanen EI. The pneumococcus: epidemiology, microbiology, and pathogenesis. Cold Spring Harb Perspect Med. 2013 Jul 1;3(7):a010215.
   PubMed Web of Science ®Google Scholar
• Bluestone CD. Clinical course, complications and sequelae of acute otitis media. Pediatr Infect Dis J. 2000 May;19(5 Suppl):S37–46.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global Vaccine Action Plan 2011-2020. Geneva. WHO: 2013 Available from https://www.afro.who.int/sites/default/files/2017-06/9789241504980_eng.pdf
   Google Scholar
• Destefano F, Pfeifer D, Nohynek H. Safety profile of pneumococcal conjugate vaccines: systematic review of pre- and post-licensure data. Bull World Health Organ. 2008 May;86(5):373–380.
   PubMed Web of Science ®Google Scholar
• Instituto de Vacunas Albert B. Sabin, Organización Panamericana de la Salud, Plan para el desarrollo acelerado y la introducción de vacunas neumocócicas de GAVI en John Hopkins, Centros para el Control y la Prevención de Enfermedades. La carga de morbilidad de la enfermedad neumocócica y la rentabilidad de una vacuna antineumocócica en América Latina y el Caribe. Revisión de las pruebas y análisis económico preliminar. Sabin Vaccine Institute: Washington D.C.; 2007.
   Google Scholar
• María MS, García F, Uribe M. Evaluación económica de la inclusión de la vacuna antineumocócica en el Plan Ampliado de Inmunización. 2008. Available from https://www.repository.fedesarrollo.org.co/bitstream/handle/11445/892/CDF_No_26_Abril_2008.pdf?sequence=1&isAllowed=y
   Google Scholar
• Castañeda-Orjuela C, Alvis-Guzmán N, Velandia-González M, et al. Cost-effectiveness of pneumococcal conjugate vaccines of 7, 10, and 13 valences in Colombian children. Vaccine. 2012 Mar 2;30(11):1936–1943.
   PubMed Web of Science ®Google Scholar
• Instituto Nacional de Salud. Vigilancia por Laboratorio de aislamientos invasores de Streptococcus pneumoniae Colombia 2006-2018. SIREVA II [Internet]. Available from https://www.ins.gov.co/buscador-eventos/Informacin%20de%20laboratorio/Vigilancia%20por%20laboratorio%20S.%20pneumoniae%202006-2018.pdf
   Google Scholar
• Wasserman M, Sings HL, Jones D, et al. Review of vaccine effectiveness assumptions used in economic evaluations of infant pneumococcal conjugate vaccine. Expert Rev Vaccines. 2018 Jan;17(1):71–78.
   PubMed Web of Science ®Google Scholar
• Carrasquilla G, Porras A, Martinez S, et al. Time -trend analysis of pneumococcal disease morbidity in children < 5 years of age after pneumococcal conjugate vaccine introduction in Colombia: An ecological study. 10th Int, Symp Pneumococci Pneumoccal Dis (ISPPD-10), Glasgow Scotland. 2016.
   Google Scholar
• Castañeda-Orjuela C, De la Hoz-Restrepo F. How cost effective is switching universal vaccination from PCV10 to PCV13? A case study from a developing country. Vaccine. 2018 Sep 11; 36(38):5766–5773.
   PubMed Web of Science ®Google Scholar
• COMPAS GroupTregnaghi MW, Sáez-Llorens X, López P, et al. Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: A double-blind randomized controlled trial. PLoS Med. 2014 Jun 3; 11(6):e1001657.
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO Position Paper on Pneumococcal conjugate vaccines in infants and children under 5 years of age. February 2019 [Internet]. Available from https://www.who.int/immunization/policy/position_papers/who_pp_pcv_2019_references.pdf
   Google Scholar
• Clarke E, Bashorun AO, Okoye M, et al. Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambia-Results of a phase 1/2 randomized, double-blinded, controlled trial. Vaccine. 2020 Jan 10;38(2):399–410.
   PubMed Web of Science ®Google Scholar
• Ministerio de Salud y Protección Social. Nota técnica unidad de pago por capitación [Internet]. Available from: https://www.minsalud.gov.co/salud/POS/Paginas/unidad-de-pago-por-capitacion-upc.aspx cited October 2022. Consulted in Nov 2022.
   Google Scholar
• Instituto de Evaluación Tecnológica en Salud. Manual para la elaboración de evaluaciones económicas en salud. Bogotá D.C: IETS; 2014.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease–United States, 1998-2003. MMWR Morb Mortal Wkly Rep. 2005 Sep 16;54(36):893–897.
   PubMedGoogle Scholar
• Atkins D, Briss PA, Eccles M, et al. GRADE Working Group. Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system. BMC Health Serv Res. 2005 Mar 23;5(1):25.
   PubMedGoogle Scholar
• Organización Panamericana de la Salud. Indicadores básicos 2019. Tendencias de la salud en las Américas: Washington D.C. Available from: https://iris.paho.org/bitstream/handle/10665.2/51543/9789275321287_spa.pdf?sequence=7&isAllowed=y
   Google Scholar
• Poehling KA, Talbot TR, Griffin MR, et al. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA. 2006 Apr 12;295(14):1668–1674.
   PubMed Web of Science ®Google Scholar
• Tsaban G, Indirect B-S-S. (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature. Vaccine. 2017 May 19; 35(22):2882–2891.
   PubMed Web of Science ®Google Scholar
• Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000;19(3):187–195.
   PubMed Web of Science ®Google Scholar
• Hansen J, Black S, Shinefield H, et al. effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than 5 years of age for prevention of pneumonia: updated analysis using World Health Organization standardized interpretation of chest radiographs. Pediatr Infect Dis J. 2006 Sep;25(9):779–781.
   PubMed Web of Science ®Google Scholar
• Departamento Administrativo Nacional de Estadística – DANE. Proyecciones de población. Serie nacional de población por área, sexo y edad para el periodo 2018 – 2070 [Internet]. Available from https://www.dane.gov.co/index.php/estadisticas-por-tema/demografia-y-poblacion/proyecciones-de-poblacion cited October 2020. Consulted in Nov 2022.
   Google Scholar
• National Collaborating Centre for Women’s and Children’s Health (UK). Bacterial Meningitis and Meningococcal Septicaemia: Management of Bacterial Meningitis and Meningococcal Septicaemia in Children and Young People Younger than 16 Years in Primary and Secondary Care. London: RCOG Press; 2010.
   Google Scholar
• Johnson AP, Waight P, Andrews N, et al. Morbidity and mortality of pneumococcal meningitis and serotypes of causative strains prior to introduction of the 7-valent conjugant pneumococcal vaccine in England. J Infect. 2007 Nov;55(5):394–399.
   PubMed Web of Science ®Google Scholar
• Ferreira S, Sant’anna CC, March Mde F, et al. Lethality by pneumonia and factors associated to death. J Pediatr (Rio J). 2014 January-February;90(1):92–97.
   PubMed Web of Science ®Google Scholar
• Ministerio de Salud y Protección Social. Registro Individual de Prestaciones de Servicios de Salud - RIPS. [Internet]. Available from: https://www.minsalud.gov.co/proteccionsocial/Paginas/rips.aspx cited March 2021, consulted in Nov 2022.
   Google Scholar
• Banco de la República de Colombia. Tasa Representativa del Mercado (TRM - Peso por dólar) [Internet]. Available from: https://www.banrep.gov.co/es/estadisticas/trm cited November 2022.
   Google Scholar
• Ministerio de Salud y Protección Social de Colombia. Sistema de información de precios de medicamentos -SISMED [Internet]. Available from: https://web.sispro.gov.co/WebPublico/Consultas/ConsultarCNPMCadenaComercializacionCircu2yPA_028_2_2.aspx cited November 2022.
   Google Scholar
• Peñaranda A, Mendieta JC, Perdomo JA, et al. Beneficios económicos del implante coclear para la hipoacusia sensorineural profunda. Rev Panam Salud Publica. 2012;31(4):325–331.
   PubMedGoogle Scholar
• Departamento Administrativo Nacional de Estadística (DANE). Boletín del Sistema Nacional de Información de Demanda Laboral - SINIDEL. [Internet]. Available from: https://www.dane.gov.co/index.php/estadisticas-por-tema/educacion/boletin-sinidel cited November 2022.
   Google Scholar
• Departamento Administrativo Nacional de Estadística (DANE). Gran encuesta integrada de hogares (GEIH) Mercado laboral. [Internet]. Available from: https://www.dane.gov.co/index.php/estadisticas-por-tema/mercado-laboral/empleo-y-desempleo/geih-historicos. cited November 2022.
   Google Scholar
• Pan American Health Organization. Immunization in the Americas. 2020 Summary [Internet]. Available from: https://www.paho.org/en/documents/immunization-summary-2020-summary cited November 2022.
   Google Scholar
• Gray BM, Dillon HC Jr. Natural history of pneumococcal infections. Pediatr Infect Dis J. 1989 Jan;8(1 Suppl):S23–5.
   PubMed Web of Science ®Google Scholar
• Waight PA, Andrews NJ, Ladhani SN, et al. effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. Lancet Infect Dis. 2015 May;15(5):535–543.
   PubMed Web of Science ®Google Scholar
• Moore MR, Link-Gelles R, Schaffner W, et al. effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. Lancet Infect Dis. 2015 Mar;15(3):301–309.
   PubMed Web of Science ®Google Scholar
• Dagan R, Patterson S, Juergens C, et al. Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial. Clin Infect Dis. 2013 Oct;57(7):952–962.
   PubMed Web of Science ®Google Scholar
• Cohen R, Levy C, Bingen E, et al. impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media. Pediatr Infect Dis J. 2012 Mar;31(3):297–301.
   PubMed Web of Science ®Google Scholar
• Finnish institute for health and welfare. Incidence of invasive pneumococcal disease in Finland [Internet]. Available from https://thl.fi/en/web/thlfi-en/research-and-development/research-and-projects/monitoring-the-population-effectiveness-of-pneumococcal-conjugate-vaccination-in-the-finnish-national-vaccination-programme/incidence-of-invasive-pneumococcal-disease-in-finland Updated in May, 2020. cited Nov 2022.
   Google Scholar
• van den Bergh MR, Spijkerman J, Swinnen KM, et al. Effects of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D-conjugate vaccine on nasopharyngeal bacterial colonization in young children: a randomized controlled trial. Clin Infect Dis. 2013 Feb;56(3):e30–9.
   PubMed Web of Science ®Google Scholar
• Knol MJ, De Melker H, Sanders L, et al. Incidence of invasive pneumococcal disease in the Netherlands up to four years after introduction of 10-valent pneumococcal conjugate vaccination. Poster Present 10th Int Symp Pneumococci Pneumococcal Dis (ISPPD); June 29, 2016; Glasgow, United Kingdom.
   Google Scholar
• Lexau CA, Lynfield R, Danila R, et al. Active Bacterial Core Surveillance Team. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA. 2005 Oct 26;294(16):2043–2051.
   PubMed Web of Science ®Google Scholar
• The World Bank. Data. Life expectancy at birth, total (years). Available from https://data.worldbank.org/indicator/SP.DYN.LE00.IN cited November 2022.
   Google Scholar
• Van WC, Huijts S, Bolkenbaas M, et al. 13-valent pneumococcal conjugate vaccine efficacy is declining with old age: results from an exploratory analysis of the CAPiTA trial. Open Forum Infect Dis. 2014;1(1):S324–5. Available from https://academic.oup.com/ofid/article/1/suppl_1/S324/2339548
   Google Scholar
• Camacho Moreno G, Imbachi LF, Leal AL, et al. Emergence of Streptococcus pneumoniae serotype 19A (Spn19A) in the pediatric population in Bogotá, Colombia as the main cause of invasive pneumococcal disease after the introduction of PCV10. Hum Vaccin Immunother. 2020 Sep 1;16(9):2300–2306.
   PubMed Web of Science ®Google Scholar
• Mott MP, Caierão J, Cunha GR, et al. Emergence of serotype 19A Streptococcus pneumoniae after PCV10 associated with a ST320 in adult population, in Porto Alegre, Brazil. Epidemiol Infect. 2019;Jan 147e93.
   PubMed Web of Science ®Google Scholar
• Brandileone MC, Almeida SCG, Minamisava R, et al. distribution of invasive Streptococcus pneumoniae serotypes before and 5 years after the introduction of 10-valent pneumococcal conjugate vaccine in Brazil. Vaccine. 2018 May 3;36(19):2559–2566.
   PubMed Web of Science ®Google Scholar
• Potin M, Fica A, Wilhem J, et al. Opinión del Comité Consultivo de Inmunizaciones Sociedad Chilena de Infectología: Vacuna neumocóccica conjugada en niños y la emergencia de serotipo 19A. Rev Chil infectología. 2016 Jun;33(3):304–306.
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO Guide on Standardization of Economic Evaluations of Immunization Programmes. No WHO/IVB/19.10. 2nd ed. Geneva; 2019. Available from https://apps.who.int/iris/bitstream/handle/10665/329389/WHO-IVB-19.10-eng.pdf cited Nov 2022.
   Google Scholar
• Loo JD, Conklin L, Fleming-Dutra KE, et al. Systematic review of the indirect effect of pneumococcal conjugate vaccine dosing schedules on pneumococcal disease and colonization. Pediatr Infect Dis J. 2014 Jan;33(Suppl 2):Suppl2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules. S161–71.
   PubMed Web of Science ®Google Scholar
• Nymark LS, Sharma T, Miller A, et al. inclusion of the value of herd immunity in economic evaluations of vaccines. A systematic review of methods used. Vaccine. 2017 Dec 14;35(49PtB):6828–6841.
   PubMedGoogle Scholar
• Angoulvant F, Cohen R, Doit C, et al. Trends in antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae isolated from nasopharyngeal flora in children with acute otitis media in France before and after 13 valent pneumococcal conjugate vaccine introduction. BMC Infect Dis. 2015 Jun 21;15:236.
   PubMed Web of Science ®Google Scholar
• Imöhl M, Reinert RR. van der Linden M. Antibiotic susceptibility rates of invasive pneumococci before and after the introduction of pneumococcal conjugate vaccination in Germany. Int J Med Microbiol. 2015 Oct;305(7):776–783.
   PubMed Web of Science ®Google Scholar
• Ben-Shimol S, Givon-Lavi N, Leibovitz E, et al. Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent/13-valent PCV. Clin Infect Dis. 2014 Dec 15;59(12):1724–1732.
   PubMed Web of Science ®Google Scholar
• Tomczyk S, Lynfield R, Schaffner W, et al. Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine. Clin Infect Dis. 2016 May 1;62(9):1119–1125.
   PubMed Web of Science ®Google Scholar
• Grijalva CG, Nuorti JP, Griffin MR. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA. 2009 Aug 19;302(7):758–766.
   PubMed Web of Science ®Google Scholar